DHSC lays down the law on reporting medicines shortages

Medicines manufacturers (marketing authorisation holders) are expected to be fully accountable for their supply chain to the UK market and required to understand the potential impact on UK patients should supplies of their products become unavailable.

This is according to new Department of Health reporting requirements for medicines shortages and discontinuations that have been agreed with the ABPI and the BGMA. The new mandatory requirements, under Part 6 of the Health Service Products (Provision and Disclosure of Information) Regulations 2018, replace the previous voluntary arrangements


Move to give Welsh pharmacies needs-based contracts

Ask Your Pharmacist Week key a 'timely' reminder of CPCS

This website is for healthcare professionals, people who work in pharmacy and pharmacy students. By clicking into any content, you confirm this describes you and that you agree to Pharmacy Magazine's Terms of Use and Privacy Policy.

We use essential, performance, functional and advertising cookies to give you a better web experience. Find out how to manage these cookies here. We also use Interest Based Advertising Cookies to display relevant advertisements on this and other websites based on your viewing behaviour. By clicking "Accept" you agree to the use of these Cookies and our Cookie Policy.